PRESSEMITTEILUNGEN

The Swiss private diagnostic laboratory will launch mSEPT9 blood testing service for colorectal cancer early detection on July 1, 2009 ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– new product/Molecular Diagnostics Press release, Berlin, Germany, and Seattle, WA, USA, June 23, 2009 – (euro [...]

Continue reading

Berlin Germany, Biomarker, Blood Sampling, Blood Testing, Cancer Detection, Chairman Board, Colorectal Cancer Screening, Diagnostic Laboratories, Diagnostic Laboratory, Dna Methylation, Eans, Epigenomics Ag, Gastroenterologists, Laboratory Diagnostics, Laboratory Network, Molecular Diagnostics, Prime Standard, Professional Laboratory, Seattle Wa Usa, True Innovation

(pressebox) Madison, WI, USA, 03.06.2009, Roche NimbleGen introduces a new high-resolution scanning instrument, the NimbleGen MS 200 Microarray Scanner. The MS 200 is the first scanner optimized to reveal the full potential and capture the complete picture from all NimbleGen DNA microarrays. This offering completes the NimbleGen DNA Microarray processing family, comprised of a high-resolution [...]

Continue reading

Auto Gain, Barcode Reader, Chromatin Immunoprecipitation, Dna Methylation, Dna Microarray, Dna Microarrays, Gene Expression, Genomic Hybridization, High Density, High Quality Image, High Throughput, Internal Calibration, Madison Wi Usa, Microarray Scanner, Microarray Technology, Ozone Reduction, Roche Nimblegen, Sensitive Scanner, Throughput Genomics, Throughput Requirements

mSEPT9 biomarker facilitates innovative blood test for colorectal cancer mSEPT9 data published in Clinical Chemistry PRESEPT Study for colorectal cancer screening with mSEPT9 well on track ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– new product/research/Molecular diagnostics Press release, Berlin, Germany, and Seattle, WA, [...]

Continue reading

Biomarker, Cancer Detection, Cancer Screening, Case Control Studies, Clinical Chemistry, Clinical Validation, Colorectal Cancer, Ddw, Digestive Disease Week, Dna Methylation, Dr Catherine, Eans, Epigenomics Ag, Gastroenterologists, Molecular Biology, Molecular Diagnostics, New Product Research, Poster Presentation, Prestigious Conference, Seattle Wa Usa

Biomarker mPITX2 for prostate cancer prognostic application successfully validated First clinical laboratory in Germany to start offering mPITX2 testing service ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– new product/research/Molecular diagnostics Press release, Berlin, Germany and Seattle, WA, USA, May 29, 2009 (euro adhoc) [...]

Continue reading

Berlin Germany, Cancer Detection, Disease Recurrence, Dna Methylation, Eans, Epigenomics Ag, Molecular Diagnostics, New Product Research, Orlando Florida Usa, Poster Presentation, Prime Standard, Prostate Cancer, Prostate Cancer Patients, Prostate Cancer Prognosis, Prostate Cancer Risk, Prostatectomy, Rational Design, Risk Groups, Seattle Wa Usa, Validation Study

Patents cover biomarker mPITX2 for prostate and breast cancer indications ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– new product/molecular diagnostics Berlin, Germany, and Seattle, WA, USA, May 13, 2009 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), a molecular diagnostics company focusing [...]

Continue reading

American Urological Association, Breast Cancer, Breast Cancer Patients, Cancer Detection, Cancer Indications, Disease Recurrence, Dna Methylation, Duke University, Epigenomics Ag, European Patent Office, Patent And Trademark Office, Patent Application, Patent Applications, Prostate Cancer, Prostate Cancer Prognosis, Seattle Wa Usa, United States Patent, United States Patent And Trademark Office, Urology Community, Validation Study

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– finances/molecular diagnostics Berlin, Germany and Seattle, WA, U.S.A., May 11, 2009 (euro adhoc) – Key Figures . Revenue: EUR 1.24 million in Q1 2009, up by 36% (Q1 2008: EUR 0.92 million) . EBIT: EUR -2.31 [...]

Continue reading

31 Million, Adhoc, Berlin Germany, Biomarker, Bioscience, Clinical Evaluation, Colorectal, Colorectal Cancer, Commercial Partnerships, Dna Methylation, Eans, Epigenomics Ag, Eur 2, Liquid Assets, Lung Cancer, Molecular Diagnostics, Prime Standard, Product Launch, Prostate Cancer, Quest Diagnostics

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– cooperations/molecular diagnostics Berlin, Germany and Seattle, WA, U.S.A., (euro adhoc) – April 28, 2009 – Epigenomics AG (Frankfurt, Prime Standard: ECX), a cancer molecular diagnostics company, today announced that it has entered into a non-exclusive licensing [...]

Continue reading

Adhoc, Berlin Germany, Cancer Death, Cancer Test, Cancer Tests, Cause Of Cancer, Dna Methylation, Eans, Elevated Psa, Epigenomics Ag, Health Outcomes, Histology, Histopathology, Molecular Diagnostic Tests, Molecular Diagnostics, Predictive Biosciences, Prime Standard, Prostate Biopsies, Prostate Cancer, Prostate Cancer Diagnosis

Test to aid in the diagnosis of lung cancer after positive CT findings ——————————————————————————– ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. ——————————————————————————– new product/companies/molecular diagnostics Berlin, Germany and Seattle, WA, U.S.A., (euro adhoc) – March 18, 2009 – Epigenomics AG (Frankfurt, Prime Standard: ECX) a cancer molecular [...]

Continue reading

Berlin Germany, Bronchial Carcinoma, Cancer Test, Chest Physician, Chest X Ray, Clinical Evaluation, Ct Findings, Ct Scanning, Diagnosis Of Lung Cancer, Diagnostic Procedures, Diagnostic Test, Dna Methylation, Endoscope, Evaluation Test, Lung Biopsy, Lung Cancer, Malignant Disease, Molecular Diagnostics, Prime Standard, Saline Solution

——————————————————————————– ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. ——————————————————————————– cooperations/Molecular Diagnostics Berlin, Germany and Seattle, WA, U.S.A. (euro adhoc) – February 25, 2009 – Epigenomics AG (Frankfurt, Prime Standard: ECX), a cancer molecular diagnostics company, today announced that it has entered into a non-exclusive licensing agreement for [...]

Continue reading

Angelman Syndromes, Berlin Germany, Biopsies, Cancer Death, Cancer Test, Cause Of Cancer, Dgx, Diagnostic Testing, Dna Methylation, Elevated Psa, Epigenomics Ag, Faulty Dna, Histology, Histopathology, Molecular Diagnostics, Prime Standard, Prostate Cancer, Prostate Cancer Diagnosis, Quest Diagnostics, Today Announced That